INTRODUCTION
============

Cell surface proteins are rapidly reorganized to ensure optimal nutrient uptake in response to environmental changes. To accomplish this, cells coordinately regulate opposing plasma membrane (PM) processes: endocytosis of existing proteins and delivery of new proteins. In response to nitrogen starvation, yeast cells make a critical switch; Tat2, a tryptophan-specific permease, is endocytosed and degraded, whereas Gap1, the general amino acid permease, is delivered to the PM ([@B48]; [@B11]). These fundamentally similar processes require the formation of transport vesicles bearing specific membrane cargos and delivery of those vesicles to distinct cellular locations. The trafficking machinery that generates vesicles and restricts vesicle fusion to appropriate target compartments is well described ([@B7]; [@B54]). In contrast, little is known about how extracellular signals drive specific trafficking events in cells.

Arrestins are critical adaptors that direct trafficking of specific cargos in response to extracellular signals. Arrestin family members contain conserved N- and C-terminal arrestin-fold domains, but can be divided into α- and β-arrestin classes based on primary sequence and structural features ([@B1]). β-Arrestins, a small, recently evolved branch of the family ([@B1]), couple agonist-induced signaling to the endocytosis of G-protein--coupled receptors (GPCRs), a large class of receptors that regulate a vast array of biological processes ([@B49]). Agonists stimulate GPCR signaling and induce receptor phosphorylation ([@B31]). β-Arrestins bind phosphorylated GPCRs and promote endocytosis by recruiting a ubiquitin ligase that ubiquitinates the receptor and β-arrestin ([@B50]) and by interacting with vesicle coat proteins, such as clathrin and clathrin adaptor complex 2 (AP-2; [@B18]; [@B32]). The postendocytic β-arrestin--GPCR interaction determines if the receptor recycles to the PM, is degraded in the lysosome, or forms an endosomal signaling complex ([@B49]). Thus, β-arrestins respond to signaling cues and regulate the trafficking of select cargos by direct interaction with vesicle coat proteins.

In comparison to β-arrestins, the widely conserved, ancestral α-arrestins are not well studied; only one of the six mammalian α-arrestins has an ascribed trafficking function. Most α-arrestins in *Saccharomyces cerevisiae* interact with and are ubiquitinated by the Rsp5 ubiquitin ligase ([@B27]; [@B21]; [@B35]). Several of these proteins regulate the endocytosis, and in some cases Rsp5-dependent ubiquitination, of specific membrane transporters ([@B35]; [@B39]; [@B38]). However, it is not clear if all α-arrestins regulate endocytosis, as systematic screens with four membrane transporters failed to identify endocytic activity for certain family members, including Aly1 and Aly2, closely related α-arrestins that are the focus of these studies ([@B38]).

Here we show that, in striking contrast to the endocytic function of other arrestins, Aly1 and Aly2, (arrestin-like yeast proteins) regulate intracellular trafficking of Gap1. Importantly, Aly1 and Aly2 copurify with clathrin and clathrin-adaptor protein (AP) complexes in vivo and interact directly with the γ-subunit of AP-1 in vitro, suggesting that, like their β-arrestin relatives, α-arrestins promote cargo incorporation into clathrin-coated vesicles (CCVs). Nutrient signaling regulates both Aly1- and Aly2-mediated trafficking. Aly2 requires Npr1, a TORC1- and nutrient-regulated kinase that stimulates Gap1 trafficking to the PM through an unknown mechanism ([@B11]), to increase Gap1 levels in intracellular compartments and at the PM. Npr1 interacts with and phosphorylates Aly2 and may directly regulate Aly2 function. Thus, these studies identify signaling and vesicle coat proteins required for α-arrestin--mediated intracellular trafficking.

MATERIALS AND METHODS
=====================

Growth Media and General Methods
--------------------------------

Synthetic complete medium (SC) was prepared as described for YNB medium in ([@B26]) with the addition of 2.5 g/l ammonium (NH~4~) sulfate, 40 μg/ml amino acids, and 20 μg/ml nucleoside bases. The same formulation lacking amino acids/nucleoside bases was used for minimal medium (MIN); required supplements were added to MIN to support growth of auxotrophic strains. Alternative nitrogen sources were used as indicated.

Cells used in phenotype analyses on plates were grown to saturation and then plated in fivefold serial dilutions with a starting concentration of 1.0 × 10^7^ cells. Plates were grown at 30°C for the time indicated in each panel. YEPD media is described in [@B22].

Plasmids were transformed into yeast using the lithium-acetate method ([@B4]).

Yeast Strains
-------------

Yeast strains used in this study are described in Table S1. Details of specific strain constructions generated for this study are as follows: *aly1*Δ *aly2*Δ double mutant cells were constructed using two different approaches. First, strain 5092 (*MAT***a** *aly1*Δ::*KanMX4*) was mated to strain 11339 (*MAT*α *aly2*Δ::*KanMX4*), the resulting diploids were sporulated and nonparental ditype (NPD) tetrads selected. Appropriate segregation was monitored for four different marker loci to verify NPD tetrads. In this way spores D2--6A, D2--4C and D12--6B were obtained, all of which carry the *aly1*Δ::*KanMX4 aly2*Δ::*KanMX4* but with a variety of additional auxotrophies and mating types (see Supplemental Table S1). Growth of *aly1*Δ *aly2*Δ spores were assayed in the presence of NaCl, LiCl, MgCl, KCl, calcofluor white, congo red, caffeine, rapamycin, and alternative carbon sources (i.e., glycerol, ethanol, sucrose, raffinose, galactose, and maltose), and all grew equivalently (data not shown).

The second approach to generating *aly1*Δ *aly2*Δ was to make consecutive gene deletions in Y2454 cells. The p314-ALY1KO plasmid was digested with ClaI/NotI and the *Nat*MX4 cassette flanked by sequence up- and downstream of the *ALY1* coding region was transformed as per ([@B17]) into Y2454 cells. Nat-resistant colonies were selected and integration site verified by PCR. Similarly, p314-ALY2KO plasmid was digested with KpnI/SpeI, and the *URA3* gene flanked by sequence up- and down-stream of the *ALY2* coding region was transformed into Y2454 cells, and uracil prototrophs were selected. Replacement of the chromosomal *ALY2* coding sequence with *URA3* was verified by PCR. To generate the *aly1*Δ *aly2*Δ mutant, the *aly1*Δ::*NatMX4* strain was used in a second knockout transformation with the KpnI/SpeI fragment of p314-ALY2KO. Phenotypes observed for *aly1*Δ::*NatMX4 aly2*Δ::*URA3* strain generated in Y2454 cells were consistent with those seen for the *aly1*Δ::*KanMX4 aly2*Δ::*KanMX4* in the BY4741 background (data not shown).

Prototrophic, homozygous diploid *aly1*ΔΔ *aly2*ΔΔ cells were obtained by mating D12--6B with D2--4C that had been transformed with pCK230 and selecting for diploids on SC-Ura^−^Lys^−^Met^−^ medium. Diploids were then transformed with pRS313 and either pRS425, pRS425-Aly1, or pRS425-Aly2.

The *bul1*Δ *bul2*Δ *aly1*Δ *aly2*Δ strain was obtained by crossing *aly1*Δ::*NatMX4 aly2*Δ::*URA3* with *bul1*Δ *bul2*Δ spore 3D (which was generated by mating and sporulating strains 861 and 16511 and selecting NPD tetrads). Sporulation of the resulting diploid gave rise to two quadruple mutants, *bul1*Δ *bul2*Δ *aly1*Δ *aly2*Δ spores 7D and 20A, which displayed equivalent sensitivities to azetidine 2-carboxylic acid (AzC) in growth assays.

The *vps4*Δ *aly1*Δ *aly2*Δ strain was obtained by crossing *aly1*Δ::*NatMX4 aly2*Δ::*URA3* with strain 5588 containing *vps4*Δ::*KanMX4*. Sporulation of the resulting diploid gave two *vps4*Δ::*KanMX4 aly1*Δ::*NatMX4 aly2*Δ::*URA3* triple mutant spores that exhibited identical sensitivities in growth assays, including sensitivity to AzC.

The *chs6*Δ *aly1*Δ *aly2*Δ strain was obtained by crossing *aly1*Δ::*NatMX4 aly2*Δ::*URA3* with strain 1324 containing *chs6*Δ::*KanMX4*. Sporulation of the resulting diploid gave two *chs6*Δ::*KanMX4 aly1*Δ::*NatMX4 aly2*Δ::*URA3* triple mutant spores and both were examined in the CFW bud scar-staining assay. Similarly, the *chs6*Δ *apl2*Δ strain was obtained by crossing cells from strain 1324 to a *MAT*α *apl2*Δ::*KanMX4* generated by sporulating the homozygous diploid deletion strain 34985. NPD tetrad products were selected from sporulation of this diploid, and proper segregation of four independent loci was monitored to confirm NPD tetrads. As expected, both of the *chs6*Δ::*KanMX4 apl2*Δ::*KanMX4* spores (9A and 9B) alleviated the bud scar defect in a *chs6*Δ::*KanMX4* cells.

The BJ5459-Npr1-MYC strain contains a chromosomally integrated Npr1--13xMyc marked with the KanMX6 cassette. The PCR product obtained from using the pFA6a-13Myc-KanMX6 plasmid ([@B36]) as template with the following primers: 1) CTCAAATAGGATAAAAAAAGGTTATATACAAATGCTTGGAAAAGAAATAAAAGTGGGGACGCTTATGAATTCGAGCTCGTTTAAAC and 2) CACACACAAGTGGATCAAAGTGAAGCACATATTGCAGGCCTAGAAAAGAAAAAGAAAAAGCAAAATAATCAACGGATCCCCGGGTTAATTAA was transformed into BJ4549 cells. Geneticin-resistant yeast colonies were selected and the integration site verified by PCR and sequence analysis. Western blot (WB) analysis indicates that a protein product of the expected size for Npr1-MYC is generated from this integration event.

The BJ5459 *npr1*Δ::*KanMX4* strain was constructed by PCR amplifying the *npr1*Δ::*KanMX4* deletion cassette from the BY4741 Open Biosystems (Rockford, IL) deletion collection (strain 2029) using the following primers: 1) GCCTACAAGGAGTTACGTGACATGCACG and 2) GCCTTGGTAAGACAATTAATGTTACCCGC.

The PCR product was transformed into BJ5459 cells and geneticin resistant colonies selected. Replacement of the chromosomal *NPR1* coding sequence with *KanMX* was verified by PCR.

Plasmids and DNA Manipulations
------------------------------

Plasmids used in this study and details of plasmid constructions are described in Supplemental Table 2. PCR amplifications were performed using HiFi Platinum Taq (Invitrogen, Beverly, MA), and all constructs were generated using PCR-based methods were confirmed by sequence analysis.

Citrulline Uptake Assays
------------------------

Citrulline uptake assays were performed as described in [@B46]. Haploid cells from the *MAT***a** deletion collection were made prototrophic by transformation with pCK283 and one of the following: pRS426, pRS426-Aly1, or pRS426-Aly2. Cells were grown to ∼3--4 × 10^6^ c/ml in MIN-0.5% NH~4~ medium, collected, and washed by filtration on a 0.45-μM HAWP filter (Millipore, Bedford, MA), and resuspended at 1 × 10^7^ cells/ml in nitrogen-free medium before uptake assays. To initiate assays, 20 μM of ^14^C-citrulline (Perkin Elmer-Cetus, Waltham, MA) was added to cells, and 100-μl aliquots were removed every 30 s over four time points. Cells were collected by filtration, washed, and placed in scintillation fluid to determine cellular incorporation of ^14^C-citrulline. Assays were performed in triplicate, and the rate of citrulline uptake (DPM/min/OD~600~) was determined. In each case, data are presented as the rate of citrulline uptake relative to the wild-type control. The average citrulline uptake of BY4741 prototrophic cells used in these assays was 3 nmol/min/OD~600~, which is similar to that reported in [@B10]. Error bars represent the SD of the mean.

β-Galactosidase Assays
----------------------

Cells used in β-galactosidase assays with the YCp*GAP1-lacZ* reporter ([@B53]) were grown to midlog phase in SC-0.5% NH~4~ medium, washed and shifted into MIN-0.5% NH~4~, MIN-0.1% GLN, or MIN-0.1% PRO for 3 h before cell harvest. Cell treatments were the same as those used before protein extractions for Gap1-green fluorescent protein (GFP) protein levels. β-Galactosidase assays were performed on three independent samples, and measurements were taken in triplicate as described in [@B8]. β-Galactosidase activity is reported as the maximum rate of OD~415~ change/min/amount of protein, and error bars represent the SD of the mean.

Fluorescence Microscopy
-----------------------

Cell imaging was performed with a Zeiss Axio Imager M1 microscope (Carl Zeiss, Jena, Germany), and images were captured with a Hamamatsu Orca-ER digital camera Bridgewater, NJ) coupled to Openlab Software 5.0.1 (Perkin Elmer-Cetus).

Homozygous diploid deletion strains (Open Biosystems) made prototrophic by transformation with pCKB230, pRS313, and one of pRS425, pRS425-Aly1, or pRS425-Aly2 were used in Gap1-GFP imaging. Cells were grown in SC-0.5% NH~4~ medium to ∼1 × 10^7^cells/ml, washed, resuspended in MIN-0.5% NH~4~, and grown for 3 h at 23°C. Cells were immobilized on concanavalin A--treated coverslips, placed in a vacuum grease chamber, and visualized in growth medium. Exposure time, microscope settings, and image adjustments made using Adobe Photoshop (San Jose, CA) were consistent for all Gap1-GFP imaging from a given experiment, allowing for direct comparisons of Gap1-GFP intensities. In Adobe Photoshop an unsharp mask filter was applied (radius of 5 pixels) and the levels adjusted equivalently for all Gap1-GFP images. Quantification of Gap1-GFP intensity at the PM was performed using ImageJ 1.39u software (<http://rsb.info.nih.gov/ij/>; National Institutes of Health, Bethesda, MD). Cell PMs were traced, and the mean pixel intensity (fluorescence) for the PM was determined. A minimum of 150 cells was counted from five fields, and the intensities were normalized to the mean pixel intensity observed for the wild-type control cells. Error bars represent the SE of the mean.

To visualize GFP- or mCherry-tagged Aly1 or Aly2, cells were grown to ∼1 × 10^7^ cells/ml in SC-Met^−^ medium to induce arrestin expression, washed, and resuspended at ∼1 × 10^8^ cells/ml in GFP-kill buffer ([@B55]) before visualization. Colocalization of GFP-tagged Aly1 and Aly2 with FM4-64 was performed as described in [@B16]. Quantification of colocalization was performed with ImageJ 1.39u software (National Institutes of Health) in a similar manner to that described in ([@B15]. Images were converted to 8-bit and merged using the ImageJ Colocalizations plugin so that only foci in both channels were observed. A minimum of 90 cells and \>200 Aly1- or Aly2-GFP foci were counted for each point. Percentage of foci colocalizing with FM4-64 out of the total number of Aly1 or Aly2 foci analyzed is presented.

Yeast Protein Purification and Immunoblotting
---------------------------------------------

Copurification studies using glutathione *S*-transferase (GST)-fused Aly1 and Aly2 were performed by transforming BJ5459 or BJ5459-Npr1-MYC cells with pKK212, pKK212-Aly1, or pKK212-Aly2. Cells were grown to midlog phase in SC-Trp^−^ medium and induced to express GST, GST-Aly1, or GST-Aly2 from the *CUP1* promoter by adding 200 μM CuSO~4~ and incubating for 1 h at 30°C. Protein extracts were obtained by glass-bead lysis in co-immunoprecipitation (CO-IP) buffer (50 mM Tris-HCl, pH 7.4, 15 mM EGTA, 100 mM NaCl, 0.2% Triton-X 100, with protease inhibitors), incubated for 2 h at 4°C with glutathione-Sepharose beads (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom), washed three times in 500 μl of CO-IP buffer, aspirated to dryness, and eluted in Laemmli buffer.

Yeast protein extracts, not for use in copurification experiments, were obtained from sodium hydroxide cell lysis and tricholoroacetic acid precipitation of proteins using an equal number of cells as starting material ([@B58]). Equal amounts of extracts were resolved by SDS-PAGE and transferred to nitrocellulose membrane for immunoblot analysis.

Immunoblots were probed with mouse monoclonal anti-GST (Covance, Emeryville, CA), mouse monoclonal anti-GFP (Covance), rabbit polyclonal anti-Myc (Covance), mouse monoclonal anti-Chc1 (gift from G. S. Payne, UCLA), rabbit polyclonal anti-Apl1 (gift from G. S. Payne), rabbit polyclonal anti-Apl2 (gift from G. S. Payne), and mouse monoclonal anti-Pgk1 (Molecular Probes, Carlsbad, CA) antibodies. In many experiments, Pgk1 is examined to ensure equivalent loading of extracts or input. To detect S-peptide--tagged proteins, the S-protein fused to horseradish peroxidase (HRP; Novagen, Madison, WI) was used. Anti-mouse and anti-rabbit secondary antibodies conjugated to HRP (GE Healthcare) and SuperSignal West Pico Chemiluminescent Substrate kit (Thermo Scientific, Rockford, IL) were used to detect immunoreactive bands, and multiple exposures of chemiluminescent signal to Kodak Biomax XAR film (Eastman Kodak, Rochester, NY) were taken for each blot.

Alternatively, for quantitative WB analysis anti-mouse and anti-rabbit secondary antibodies conjugated to Alexa flours (Invitrogen) were used, and images obtained using an Odyssey imager and software (LI-COR Biosciences, Lincoln, NE). Quantification of WBs was performed using ImageJ 1.39u software (National Institutes of Health).

GST-Npr1 used for in vitro kinase assays was purified from Y258 yeast cells ([@B63]) by glass-bead lysis in (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EGTA, 0.1% Triton X-100, 0.1% β-mercaptoethanol) with protease inhibitors and binding to glutathione-Sepharose beads (GE Healthcare). Glutathione-bound GST-Npr1 was washed three times in the same buffer as used in the lysis with the addition of 750 mM NaCl and 1% Triton X-100 (to help limit the number of proteins copurifying with Npr1), eluted off beads in this buffer with 10 mM reduced glutathione and dialyzed in phosphate-buffered saline (PBS; 80.2 mM K~2~HPO~4~, 19.8 mM KH~2~PO~4~, 150 mM NaCl) overnight. To ensure resolution of Npr1 (which autophosphorylates) from pET-Aly2, the GST tag was removed via thrombin digestion (incubated with 3 pg/μl thrombin at 4°C overnight). Cleaved GST and uncleaved GST-Npr1 were removed by incubation with glutathione-Sepharose beads, and the unbound, cleaved Npr1 was dialyzed overnight in PBS.

Bacterial Protein Purifications
-------------------------------

pGEX-KG, pGPB1013, pGPB828, and pGPB1025 ([@B61]) were transformed into BL21-DE3 pLys (Invitrogen) *Escherichia coli*. Cultures were grown to OD~600~ = 1.0 at 37°C, induced to express GST-fusion proteins with 1 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG), and grown an additional 2 h at 37°C. Cell lysates were generated by sonication in PBS with protease inhibitors. After lysis, 1% Triton X-100 was added, and insoluble material removed by two sequential centrifugations at 15,000 × *g* for 20 min. GST-proteins were purified on glutathione-Sepharose beads and washed in PBS with an additional 500 mM NaCl.

pET-fusion constructs for Aly1 and Aly2 were transformed into BL21-DE3 Star (Invitrogen) *E. coli*. Cultures were grown to OD~600~ = 1.0 at 30°C, induced to express pET-fusion proteins with 1 mM IPTG, and grown an additional 5 h at 23°C. Cell lysates were generated by sonication in extraction buffer (50 mM Tris-HCl, pH 8, 300 mM NaCl, 0.1% NP-40, 10 mM imidazole, PMSF and benzamidine) followed by two sequential centrifugations at 15,000 × *g* for 20 min to remove insoluble material. pET-fusion proteins were purified on Ni-NTA agarose (5 PRIME, Hamburg, Germany), washed with 20 bed-volumes of wash buffer (same as extraction buffer with 20 mM imidazole), and eluted in two-bed volumes of elution buffer (same as extraction buffer with 250 mM imidazole). Proteins were dialyzed overnight in PBS before use in copurification studies.

In Vitro Kinase Assays
----------------------

pET and pET-Aly2 were incubated for 30 min at 30°C in kinase buffer (50 mM Tris-HCl, pH 7.5, 20 mM MgCl~2~, 1 mM DTT, 1 μM unlabeled ATP, aprotinin, and leupeptin) with 75 nM \[γ-^32^P\]ATP (Perkin Elmer-Cetus) with or without Npr1 kinase (purified from Y258 yeast cells). Unincorporated ^32^P was removed using a Centri-Sep spin column (Princeton Separations, Adelphia, NJ). Protein samples were resolved on 4--15% acrylamide gels by SDS-PAGE. Gels were stained with Gel Code Blue (Bio-Rad, Hercules, CA) or dried, exposed to a phosphoimager screen, and imaged with a Typhoon scanner (GE Healthcare).

RESULTS
=======

Aly1 and Aly2 Regulate Yeast Response to Nitrogen Starvation
------------------------------------------------------------

We sought to identify trafficking functions for the uncharacterized α-arrestins, Aly1 and Aly2. Other α-arrestins regulate nutrient permeases; to determine if Aly1 and Aly2 regulate nutrient responses, we examined the growth of *aly1*Δ or *aly2*Δ cells in the presence of rapamycin, a TORC1-inhibitor that mimics nitrogen starvation ([@B62]). *aly1*Δ and *aly2*Δ cells were sensitive to this drug, whereas cells overexpressing *ALY1* or *ALY2* were rapamycin resistant ([Figure 1](#F1){ref-type="fig"}A). *aly1*Δ *aly2*Δ cells were more sensitive to rapamycin than either single mutant. Thus, these gene products promote growth under nitrogen limiting conditions and may function in distinct pathways.

![Aly1 and Aly2 assist in adaptation to nitrogen starvation. (A) Growth of wild-type (WT; BY4741), *aly1*Δ (5092), *aly2*Δ (1339), and *aly1*Δ *aly2*Δ (D2--6A) or WT cells with pRS426, -*ALY1* or -*ALY2* on YEPD ± rapamycin. (B) Growth of WT (BY4741), *aly1*Δ (5092), *aly2*Δ (1339), and *aly1*Δ *aly2*Δ (D2--6A) or WT cells with pRS425, -*ALY1* or -*ALY2* on MIN-0.25% NH~4~ ± amino acid analog. (C) WT (BY4741), *aly1*Δ (5092), *aly2*Δ (1339), and *aly1*Δ *aly2*Δ (D2--6A) with pCK283 and pRS426 or (D) WT (BY4741) cells with pCK283 and pRS426, -*ALY1*, or -*ALY2* were assayed for \[^14^C\]citrulline uptake. The mean uptake rate ± SDM for three replicates is shown as % relative to WT.](zmk0201096070001){#F1}

When nitrogen is limiting, yeast import and metabolize amino acids as a nitrogen source. To test if Aly1 and Aly2 alter amino acid uptake, we monitored growth of *aly1*Δ or *aly2*Δ mutants in the presence of toxic amino acid analogs. Cells lacking *ALY1* and/or *ALY2* were resistant to AzC and canavanine, toxic analogs of proline and arginine, respectively ([Figure 1](#F1){ref-type="fig"}B). Conversely, cells overexpressing *ALY1* or *ALY2* were sensitive to these compounds ([Figure 1](#F1){ref-type="fig"}B). These phenotypes suggest that Aly1 and Aly2 elevate cell surface localization and/or activity of the permeases required for analog uptake. AzC enters cells through several permeases, including Gap1 and Put4, whereas canavanine enters via the Can1 permease ([@B20]; [@B2]). Nitrogen-dependent regulation of Gap1 trafficking is well characterized; therefore, we next examined whether Aly1 and Aly2 influence activity of this permease. Gap1 activity at the cell surface was determined in cells lacking or overexpressing *ALY1* and/or *ALY2* by measuring uptake of \[^14^C\]citrulline, which is transported exclusively by Gap1 ([@B19]; Figure S1A). \[^14^C\]citrulline uptake in *aly1*Δ, *aly2*Δ, or *aly1*Δ *aly2*Δ cells occurs at half the rate of wild-type cells ([Figure 1](#F1){ref-type="fig"}C and Figure S1A), whereas cells overexpressing *ALY1* or *ALY2* transported citrulline at almost twice the rate of vector control cells ([Figure 1](#F1){ref-type="fig"}D). Thus, Aly1 and Aly2 increase Gap1 activity and/or levels at the PM and may regulate additional permeases (e.g., Can1 and Put4). However, Aly1 and Aly2 affect only a subset of permeases, as cells lacking or overexpressing *ALY1* and/or *ALY2* grew equivalently to wild-type cells in the presence of thialysine, a toxic lysine analog imported by Lyp1 ([@B20]; [Figure 1](#F1){ref-type="fig"}B). Increased Gap1 transport activity upon Aly1 or Aly2 overexpression is inconsistent with a role for Aly1 and Aly2 in promoting Gap1 endocytosis and rather suggests a novel function for these arrestins in increasing the amount of PM-localized Gap1.

Aly1 and Aly2 Copurify with Gap1 and Increase Gap1 Levels
---------------------------------------------------------

To test if Aly1 and Aly2 interact with Gap1, GST-fused Aly1 or Aly2 was isolated from extracts of cells expressing Gap1-GFP. Aly1 and Aly2 both copurified with Gap1 ([Figure 2](#F2){ref-type="fig"}A), suggesting that they act directly on this permease to alter its activity and/or levels at the PM.

![Aly1 and Aly2 interact with and increase Gap1 levels. (A) GST (pKK212), GST-Aly1 (pKK212-Aly1), and GST-Aly2 (pKK212-Aly2) were purified from Gap1-GFP (pAR13) containing BJ5459 cells grown in SC-0.1% PRO and copurification assessed by WB. Samples were run on one gel, but line denotes lane removal. (B) Extracts from prototrophic WT (BY4743) or *aly1*ΔΔ *aly2*ΔΔ cells with Gap1-GFP (pCK230), pRS313 and pRS425 grown in SC-0.5% NH~4~, washed, and grown for 3 h in MIN-0.5% NH~4~ were assessed by WB. The mean band intensity for three replicates ± SDM is plotted relative to the WT. (C and D) The same cells as in B were visualized using fluorescence microscopy (scale bar, 5 μm; C), and PM fluorescence intensity was quantified (D). Mean PM fluorescence intensity ± SEM is plotted relative to WT.](zmk0201096070002){#F2}

Gap1 trafficking is well characterized making it an excellent model for exploring Aly1 and Aly2 trafficking functions. Gap1 is a high-affinity transporter for a broad spectrum of amino acids, which can be scavenged for use as a nitrogen source. Cells grown on a preferred nitrogen source, such as glutamine, do not require PM-localized Gap1, and newly synthesized Gap1 is sorted from the *trans*-Golgi network (TGN) to endosomes and on to the vacuole for degradation ([Figure 3](#F3){ref-type="fig"}A). This TGN-to-vacuole sorting of Gap1 is regulated by Bul1 and Bul2, two adaptors for the Rsp5-ubiqutin ligase, and requires poly-ubiquitination of Gap1 by Rsp5 ([@B23]; [@B52]; [@B33]). In cells grown on a poor nitrogen source, such as proline, Gap1 traffics from the TGN to the PM, where it assists in nitrogen uptake ([Figure 3](#F3){ref-type="fig"}A). Nitrogen supply also regulates Gap1 recycling from endosomes to the TGN; preferred nitrogen sources inhibit recycling, whereas amino acid starvation or growth on a poor nitrogen source activates recycling ([@B47]; [Figure 3](#F3){ref-type="fig"}A). Finally, nutrients regulate Gap1 endocytosis with addition of high concentrations of amino acids or a preferred nitrogen source triggering permease internalization ([@B11]; [@B44]). We monitored the impact of Aly1 and Aly2 on Gap1 trafficking under a range of nutrient conditions.

![Aly1 and Aly2 regulate Gap1 recycling from endosomes. (A) Gap1 trafficking in response to nutrient supply. Gap1-trafficking pathways (black arrows), nutrients that promote (green arrow) or inhibit (red bar) trafficking, and proteins needed for a trafficking interval (colored boxes) are indicated. Growth in glutamine (GLN), a preferred nitrogen source, inhibits Gap1 delivery to PM and promotes TGN-to-MVB/vacuole trafficking by stimulating polyubiquitination of Gap1 by Bul1/Bul2/Rsp5 ([@B23]; [@B52]; [@B33]). Growth in proline (PRO), a poor nitrogen source, promotes Gap1 TGN-to-PM trafficking and inhibits TGN-to-MVB/vacuole trafficking. Gap1 recycling from endosomes-to-TGN requires Lst4 and is inhibited by amino acids ([@B45]; [@B47]). Gap1 at the PM undergoes Rsp5-dependent endocytosis when amino acids or a preferred nitrogen source are added ([@B11]; [@B44]). For most of our experiments, cells were grown in NH~4~, a nitrogen source of intermediate quality. Under these conditions, some Gap1 is delivered to the PM and some is delivered to the MVB/vacuole for degradation. EE, early endosome; Vac, vacuole. (B) WT (BY4741) or *aly1*Δ*aly2*Δ (D2--6A) cells with Gap1-GFP (pCK230) were grown in MIN-0.2% urea and incubated with 50 μg/ml CHX for 20 min. At 0 min (Gap1 localization shown; scale bar, 5 μm), 0.1% casamino acids was added to trigger Gap1 endocytosis. Band intensities were measured, and the mean % of Gap1 remaining, as determined from three replicates, is shown ±SDM. Growth in MIN-0.5% NH~4~ gave similar results (data not shown). (C) Extracts from WT (BY4741), *aly1*Δ (5092), *aly2*Δ (1339), and *aly1*Δ*aly2*Δ (D2--6A) cells with Gap1-GFP (pCK230) grown in SC-0.5% NH~4~, washed, and grown for 3 h in MIN-0.1% GLN or MIN-0.1% PRO were assessed by WB. The two exposures shown, 1 min short exp. and 10 min long exp., allow comparison of protein levels. (D) Growth of WT (BY4741), *aly1*Δ::*NatMX4 aly2*Δ::*URA3*, *bul1*Δ *bul2*Δ (spore 3A), and *bul1*Δ *bul2*Δ *aly1*Δ *aly2*Δ (spore 7D) on MIN-0.5% NH~4~ ± AzC. (E) WT (BY4741) or *aly1*Δ *aly2*Δ (D2--6A) cells with pCK283 and pRS426 were grown in either MIN-0.1% GLN or MIN-0.1% glutamate (GLU), transferred to MIN-0.1% urea with 1.5 μg/ml CHX and the kinetics of Gap1 trafficking to the PM monitored by \[^14^C\]citrulline uptake. The mean uptake rate (DPM/min/OD~600~) for two independent samples ± SEM is plotted.](zmk0201096070003){#F3}

We examined Gap1-GFP levels and localization in *aly1*Δ *aly2*Δ cells under conditions that allow Gap1 localization to the PM (i.e., growth in amino acid--free medium with ammonium (NH~4~), an intermediate quality nitrogen source that allows some Gap1 delivery to the PM and some to the MVB-vacuole; see [Figure 3](#F3){ref-type="fig"}A). Compared with wild-type cells, levels of total ([Figure 2](#F2){ref-type="fig"}B) and PM-localized Gap1-GFP ([Figure 2](#F2){ref-type="fig"}, C and D) were reduced by twofold in *aly1*Δ *aly2*Δ cells. Thus, in *aly1*Δ *aly2*Δ cells the slower citrulline uptake rates ([Figure 1](#F1){ref-type="fig"}C) can be explained by reduced amounts of Gap1 at the PM.

Gap1 protein levels are not only altered by changes in its trafficking, but are also altered by nutrient-regulated changes in *GAP1* gene expression. To determine whether Aly1 or Aly2 modulate *GAP1* transcription, we monitored expression of a *GAP1* promoter-*lacZ* fusion ([@B53]). Neither deletion nor overexpression of *ALY1* or *ALY2* affected activity of the P*~GAP1~-lacZ* reporter under any condition used in these studies (Figures S1, B--D). Thus, Aly1 and Aly2 interact with Gap1 and act posttranscriptionally to increase Gap1 protein levels, including Gap1 at the PM.

Aly1 and Aly2 Do Not Influence Gap1 Endocytosis
-----------------------------------------------

Decreased total and PM-localized Gap1 in *aly1*Δ *aly2*Δ cells indicates that more Gap1 traffics to the vacuole in this strain. Increased vacuolar degradation of Gap1 could result from: 1) increased endocytosis, 2) impaired Gap1 trafficking from the trans-Golgi network (TGN) to the PM, or 3) impaired Gap1 recycling from endosomes to the TGN. To determine which of these is operative, we first examined endocytosis of Gap1 in wild-type and *aly1*Δ *aly2*Δ cells under conditions that allow Gap1 trafficking to the PM ([Figure 3](#F3){ref-type="fig"}B). Gap1-GFP levels were monitored in cycloheximide-treated cells after addition of casamino acids, which triggers endocytosis and inhibits endosome-TGN recycling ([@B44]) ([Figure 3](#F3){ref-type="fig"}A). Under these conditions, Gap1 degradation occurs predominantly through endocytic turnover, and this is unchanged in *aly1*Δ *aly2*Δ cells ([Figure 3](#F3){ref-type="fig"}B). Thus, Gap1 reduction in *aly1*Δ *aly2*Δ cells is not due to increased endocytosis. Consistent with this conclusion, *ALY1* and *ALY2* overexpression increased AzC sensitivity equivalently in wild-type and *end3*Δ cells, which are defective for Gap1 endocytosis ([@B37]) (Figure S2A). Therefore, Aly1 and Aly2 increase Gap1 levels through an endocytosis-independent mechanism.

Aly1 and Aly2 Are Not Required for Gap1 Delivery from the TGN to the PM
-----------------------------------------------------------------------

Next, we investigated effects of Aly1 and Aly2 on Gap1 trafficking under two different nutrient conditions. First, Gap1 levels were examined in cells grown on proline, a poor nitrogen source that stimulates Gap1 trafficking from the TGN-to-PM and inhibits its delivery to the MVB/vacuole ([Figure 3](#F3){ref-type="fig"}A). Growth in proline results in much higher Gap1 levels than growth in glutamine, a preferred nitrogen source that promotes TGN sorting of Gap1 to the MVB ([Figure 3](#F3){ref-type="fig"}A). Loss of *ALY1* and *ALY2* had little effect on Gap1 levels in proline-grown cells ([Figure 3](#F3){ref-type="fig"}C; short exp.), which is inconsistent with roles for these proteins in delivering Gap1 from the TGN to the PM. In contrast, Gap1 was significantly reduced in *aly1*Δ *aly2*Δ cells grown in glutamine, suggesting that Aly1 and Aly2 influence Gap1 abundance only when TGN-to-MVB sorting of the permease is active ([Figure 3](#F3){ref-type="fig"}C; long exp., and see next section).

We also examined Aly1 and Aly2 function in cells lacking Bul1 and Bul2, Rsp5-adaptors that promote polyubiquitination of Gap1 and that are required for delivery of the permease to the vacuole ([@B23]; [@B52]; [@B33]; [Figure 3](#F3){ref-type="fig"}A). In *bul1*Δ *bul2*Δ cells, Gap1 is constitutively delivered to the PM, resulting in severe AzC sensitivity ([@B23]; [@B52]; [Figure 3](#F3){ref-type="fig"}D). We found that *bul1*Δ *bul2*Δ and *aly1*Δ *aly2*Δ *bul1*Δ *bul2*Δ cells displayed equivalent sensitivity to AzC ([Figure 3](#F3){ref-type="fig"}D). Thus, under two different conditions where TGN-to-PM trafficking of Gap1 predominates, loss of Aly1 and Aly2 have little effect on Gap1 levels or activity. We conclude that Aly1 and Aly2 are not required for TGN-to-PM trafficking of Gap1.

Aly1 and Aly2 Promote Amino Acid--regulated Recycling of Gap1 from Endosomes
----------------------------------------------------------------------------

The findings described above are consistent with functions for Aly1 and Aly2 in endosomal recycling of Gap1. First, loss of Aly1 and Aly2 significantly decreased Gap1 levels in glutamine-grown cells ([Figure 3](#F3){ref-type="fig"}C, long exp.), where Gap1 cycling from endosomes to the TGN contributes significantly to steady-state levels by rescuing Gap1 from vacuolar degradation ([@B47]; [@B44]). In proline-grown cells, where recycling from endosomes is inhibited, loss of Aly1 and Aly2 had little effect on Gap1 levels. Second, previous work has shown that mutations compromising the MVB-to-TGN recycling of Gap1 have no effect in *bul1*Δ *bul2*Δ cells, because deleting *BUL1* and *BUL2* blocks Gap1 delivery to the MVB and eliminates the pool of Gap1 acted on by recycling proteins ([@B23]; [@B43]; [@B47]). As described above, *aly1*Δ *aly2*Δ, similar to other recycling mutants, do not alter AzC sensitivity of *bul1*Δ *bul2*Δ ([Figure 3](#F3){ref-type="fig"}D).

Observations in *vps4*Δ cells also suggested that Aly1 and Aly2 function in endosomal recycling (Figure S2, B and C). In *vps4*Δ cells the ESCRT-III complex and MVB formation are defective, resulting in inefficient degradation of Gap1. Gap1 accumulates in aberrant, prevacuolar "class E" compartments ([@B41]) from which it recycles to the PM causing AzC sensitivity ([@B47]). *aly1*Δ *aly2*Δ *vps4*Δ cells are less sensitive to AzC than *vps4*Δ cells, indicating that Gap1 recycling is partially dependent on Aly1 and Aly2 (Figure S2B), whereas overexpression of *ALY1* and *ALY2* in *vps4*Δ cells increases AzC sensitivity (Figure S2C), consistent with a role for Aly proteins in recycling Gap1 from the class E, prevacuolar compartment.

To examine nutrient-regulated endosomal recycling of Gap1 directly, Gap1 activity was monitored after transferring cells grown in glutamate (a good nitrogen source) to medium containing urea (a poor nitrogen source) and cycloheximide (CHX). These conditions trigger redistribution of Gap1 from intracellular reserves to the PM while preventing new Gap1 synthesis ([@B46]). In wild-type cells transferred from glutamate to urea/CHX, \[^14^C\]citrulline uptake increased quickly and peaked at 15 min, indicating efficient redistribution of Gap1 from intracellular stores to the PM ([Figure 3](#F3){ref-type="fig"}E). In contrast, no increase in Gap1 activity at the PM was observed for *aly1*Δ *aly2*Δ cells under these conditions, indicating that Aly1 and Aly2 are important for maintaining intracellular Gap1 and/or delivering Gap1 from intracellular stores to the PM (either directly or through intermediate compartments such as the TGN), in response to nutrients. No uptake was observed for either wild-type or *aly1*Δ *aly2*Δ cells shifted from glutamine to urea/CHX, because synthesis of Gap1 protein is required to restore activity under these conditions ([@B46]; [Figure 3](#F3){ref-type="fig"}E).

Amino acids inhibit recycling of Gap1 from endosomes ([@B47]). Therefore, we examined Gap1 in cells overexpressing *ALY1* or *ALY2* that were grown in amino acid--rich medium and transferred to amino acid--free medium, which releases the recycling block ([Figure 3](#F3){ref-type="fig"}A). *ALY1* or *ALY2* overexpression had no significant effect on Gap1 levels or localization when recycling was inhibited ([Figure 4](#F4){ref-type="fig"}, A and B). However, when endosome-to-TGN recycling was active, *ALY1* and *ALY2* overexpression caused a twofold increase in Gap1 abundance ([Figure 4](#F4){ref-type="fig"}A), resulting in higher Gap1 levels at the PM and in intracellular compartments as determined by fluorescence microscopy ([Figure 4](#F4){ref-type="fig"}, B and C). This twofold increase in Gap1 levels at the PM when *ALY1* or *ALY2* are overexpressed ([Figure 4](#F4){ref-type="fig"}C) is supported by the twofold increase in citrulline uptake observed under these same conditions ([Figure 1](#F1){ref-type="fig"}D). Consistent with the *ALY1* and *ALY2* overexpression results ([Figure 4](#F4){ref-type="fig"}, A--C), when endosome-to-TGN recycling is active *aly1*Δ *aly2*Δ cells displayed reduced levels of total and PM-localized Gap1-GFP compared with wild-type cells ([Figure 2](#F2){ref-type="fig"}, B--D).

![Aly1 and Aly2 regulate Gap1 recycling in response to amino acid starvation. (A) Extracts from prototrophic WT (BY4743) cells with Gap1-GFP (pCK230), pRS313 and pRS425, -Aly1 or -Aly2 grown in SC-0.5% NH~4~ (Amino Acid Rich/MVB-TGN recycling inhibited), washed, and grown for 3 h in MIN-0.5% NH~4~ (No Amino Acids/MVB-TGN recycling active) were assessed by WB. The mean band intensity for three replicates ± SDM is plotted relative to the WT. (B and C) Cells grown as in A were B visualized using fluorescence microscopy (scale bar, 5 μm), and (C) the mean Gap1 PM fluorescence intensity (for MIN-0.5% NH~4~ grown cells) ± SEM is plotted relative to WT.](zmk0201096070004){#F4}

These data support a role for Aly1 and Aly2 in the nutrient-regulated recycling of Gap1 from endosomes to the TGN and/or PM. By promoting Gap1 recycling, Aly1 and Aly2 rescue Gap1 from vacuolar-degradation pathways and increase Gap1 protein levels, both within internal membranes and at the PM. These findings establish a novel function for arrestins as regulators of intracellular protein sorting.

Aly2-mediated Gap1 Recycling Requires Lst4
------------------------------------------

We next sought to determine if Aly1 or Aly2 regulate Gap1 in conjunction with other Gap1 recycling factors. Lst4 promotes an amino acid--regulated Gap1 recycling pathway from endosomes to the PM, proposed to transit through a TGN intermediate ([@B45]; [@B47]; [Figures 3](#F3){ref-type="fig"}A and [9](#F9){ref-type="fig"}). In *lst4*Δ cells, Gap1 is constitutively sorted to the vacuole and degraded resulting in resistance to AzC ([Figure 5](#F5){ref-type="fig"}A) and a 10-fold reduction Gap1 activity compared with wild-type cells ([@B45]; [@B47]; [Figure 5](#F5){ref-type="fig"}C and Figure S1A). To determine if Aly1 and Aly2 influence Gap1 trafficking through an Lst4-dependent or independent mechanism, we explored the effects of overexpressing *Aly1* or *Aly2* in *lst4*Δ cells.

![Aly1, but not Aly2, restores Gap1 PM-localization in *lst4*Δ. (A) Growth of WT (BY4741) or *lst4*Δ (5026) cells with pRS425, pRS425-Aly1, or pRS425-Aly2 on MIN-0.5% NH~4~ ± AzC. (B and D) Prototrophic *lst4*ΔΔ (35026) cells with pCK230 (Gap1-GFP), pRS313, and pRS425, -Aly1, or -Aly2 were grown in SC-0.5% NH~4~, washed, and grown for 3 h in MIN-0.5% NH~4~. (B) Cell extracts were assessed by WB. (D) Gap1-GFP was visualized by fluorescence microscopy (scale bar, 5 μm). (C) Prototrophic WT (BY4741) and *lst4*Δ (5026) cells with pCK283 and pRS426, -*ALY1*, or -*ALY2* were assayed for \[^14^C\]citrulline uptake. The mean uptake rate ± SDM for three replicates is shown as % relative to WT.](zmk0201096070005){#F5}

Overexpression of *ALY1* in *lst4*Δ mutants increased sensitivity to AzC compared with vector-containing cells ([Figure 5](#F5){ref-type="fig"}A). In addition, *ALY1* overexpression increased Gap1 levels ([Figure 5](#F5){ref-type="fig"}B), Gap1 activity (fivefold faster rate of citrulline uptake compared with the *lst4*Δ with vector control; [Figure 5](#F5){ref-type="fig"}C), and PM-localization of Gap1 ([Figure 5](#F5){ref-type="fig"}D) in *lst4*Δ cells. These data indicate that Aly1 regulates an Lst4-independent Gap1 trafficking pathway that partially bypasses vacuolar sorting of Gap1 in *lst4*Δ cells. In marked contrast, *ALY2* overexpression in *lst4*Δ cells failed to confer the same degree of AzC sensitivity as *ALY1* overexpression ([Figure 5](#F5){ref-type="fig"}A) and failed to increase Gap1 levels ([Figure 5](#F5){ref-type="fig"}B), activity ([Figure 5](#F5){ref-type="fig"}C), or PM localization ([Figure 5](#F5){ref-type="fig"}D) in comparison with *lst4*Δ containing a vector control. Thus, in contrast to Aly1, Aly2 primarily influences Lst4-dependent Gap1-trafficking (see [Figure 9](#F9){ref-type="fig"}).

Aly2 Interacts with and Requires Npr1 to Mediate Gap1 Trafficking
-----------------------------------------------------------------

Npr1, the nutrient permease reactivator kinase, is active under nitrogen-limiting conditions and is inhibited in a TORC1-dependent manner during growth in preferred nitrogen ([@B48]). Npr1 is required for Gap1 targeting to the PM, although substrates that mediate this regulation have not been identified ([@B11]). Analysis of Aly1 and Aly2 copurifying proteins by mass spectrometry (MS) identified Npr1 peptides in Aly2-, but not Aly1-containing complexes (data not shown). We verified the Aly2-Npr1 interaction by reciprocal copurifications with chromosomally Myc-tagged Npr1 and GST-fused Aly2, under both good and poor nitrogen conditions ([Figure 6](#F6){ref-type="fig"}A and data not shown). In contrast, Npr1-Myc did not copurify with GST or GST-Aly1 under any of the nutrient conditions tested ([Figure 6](#F6){ref-type="fig"}A and data not shown).

![Aly2 interacts with and requires Npr1 to promote Gap1 PM-localization. (A) BJ5459 or BJ5459-Npr1-MYC cells expressing GST (pKK212), GST-Aly1 (pKK212-Aly1), or GST-Aly2 (pKK212-Aly2) were grown in SC-0.25% NH~4~. Protein extracts were split, with half used for GST and half for anti-MYC Ab purifications, and copurification assessed by WB. Samples were run on one gel, but line denotes lane removal. (B) WT (BY4741) or *npr1*Δ (2029) cells with pRS425, -Aly1 or -Aly2 were grown in MIN-0.25% NH~4~, washed, and inoculated at equal density into either MIN-0.1% GLN or MIN-0.1% citrulline (CIT). Growth was monitored using OD~600~ readings, taken every 30 min with a Tecan Genios microtiter plate reader. (C) Growth of WT (BY4741) or *npr1*Δ (2029) cells with pRS425, -Aly1, or -Aly2 on MIN-0.5% NH~4~ ± AzC. (D) Prototrophic WT (BY4741) and *npr1*Δ (2029) with pCK283 and pRS426, -*ALY1*, or -*ALY2* were assayed for \[^14^C\]citrulline uptake. The mean uptake rate ± SDM for three replicates is shown as % relative to WT. (E and F) Prototrophic *npr1*ΔΔ (32029) cells with Gap1-GFP (pCK230), pRS313 and pRS425, -Aly1, or -Aly2 were grown in SC-0.5% NH~4~, washed, and grown for 3 h in MIN-0.5% NH~4~ and (E) cell extracts were assessed by WB or (F) Gap1-GFP was visualized using fluorescence microscopy (scale bar, 5 μm). (G) GST-Aly1 (pKK212-Aly1) or -Aly2 (pKK212-Aly2) were purified from extracts of WT (BJ5459) or *npr1*Δ (BJ5459-*npr1*Δ::*KanMX*) cells grown in SC-0.25% NH~4~ and assessed by WB. Similar results were obtained using GFP-Aly1 and -Aly2 extracted from WT (BY4741) or *npr1*Δ (2029) cells (data not shown). Phosphorylation of GST-Aly2 was further analyzed using mock (−) or lambda phosphatase treatment (λ-PP). (H) pET and pET-Aly2 were purified from *E. coli* and incubated with \[γ-^32^P\]ATP kinase cocktail in the presence (+) or absence (−) of Npr1. Proteins were analyzed by SDS-PAGE and imaged on a Typhoon scanner for ^32^P quantification or stained for total protein. pET-Aly2 phosphorylation ± Npr1 is shown (left-hand portion of panel). The mean fold-increase in phospho-signal upon addition of Npr1 kinase (normalized for loading) is plotted from three replicate experiments ± SDM for both pET-Aly2 and the pET tag alone (the latter is not phosphorylated by Npr1) in the right-hand portion of the panel.](zmk0201096070006){#F6}

To explore possible functional interactions between Npr1, Aly1, and Aly2, we examined the impact of *ALY1* and *ALY2* overexpression on *npr1*Δ cells. *npr1*Δ cells constitutively deliver Gap1 to the vacuole under all nutrient conditions and so have less Gap1 at the PM, cannot utilize citrulline as a nitrogen source, and are resistant to AzC ([@B11]; [@B52]; [@B6]). Overexpression of *ALY1* in *npr1*Δ cells rescued growth on citrulline as a nitrogen source ([Figure 6](#F6){ref-type="fig"}B) and increased AzC sensitivity ([Figure 6](#F6){ref-type="fig"}C), Gap1 activity (2.5-fold) ([Figure 6](#F6){ref-type="fig"}D), Gap1 levels ([Figure 6](#F6){ref-type="fig"}E), and Gap1 localization to intracellular patches and the PM ([Figure 6](#F6){ref-type="fig"}F) in comparison to vector-containing cells. In contrast, *Aly2* overexpression failed to rescue *npr1*Δ growth on citrulline ([Figure 6](#F6){ref-type="fig"}B) or increase the AzC sensitivity of *npr1*Δ cells ([Figure 6](#F6){ref-type="fig"}C). In addition, Gap1 levels ([Figure 6](#F6){ref-type="fig"}E) and Gap1 activity ([Figure 6](#F6){ref-type="fig"}D) were only modestly increased when *Aly2* was overexpressed in comparison to *npr1*Δ cells containing the vector control. There was no significant change in Gap1 localization in *Aly2* overexpressing cells compared with the vector in *npr1*Δ ([Figure 6](#F6){ref-type="fig"}F). Together, these findings show that regulation of Gap1 trafficking by Aly1 is independent of Npr1, whereas Aly2 acts primarily through an Npr1-dependent mechanism.

To determine if Aly1 or Aly2 are Npr1 substrates, we examined their electrophoretic mobility in *npr1*Δ cells. The electrophoretic mobility of Aly1 is identical in extracts of *npr1*Δ and wild-type cells ([Figure 6](#F6){ref-type="fig"}G). In contrast, the electrophoretic mobility of Aly2 was increased in extracts of *npr1*Δ cells relative to wild-type cells, and this difference was abolished by phosphatase treatment ([Figure 6](#F6){ref-type="fig"}G), suggesting Npr1-dependent phosphorylation of Aly2. To examine direct phosphorylation by Npr1, S-tagged Aly2 or S-tag control protein was purified from *E. coli* and incubated in vitro with purified Npr1 in the presence of ^32^P-γ-ATP ([@B3]). Npr1 phosphorylated Aly2 but not the S-tag alone, with a twofold increase in Aly2 phospho-signal in the presence of Npr1 compared with mock treatment, whereas the S-tag control phospho-signal is unchanged ([Figure 6](#F6){ref-type="fig"}H). Thus, Aly2 serves as an Npr1 substrate in vitro. In this in vitro assay, the electrophoretic mobility of Aly2 does not change after phosphorylation by Npr1, perhaps because some phosphorylation sites are accessible only when Aly2 is bound to cargo and other intracellular regulators. Alternatively, the shift observed in wild-type versus *npr1*Δ extracts may be a combined result of direct phosphorylation and Npr1-dependent regulation of additional kinases/phosphatases that act on Aly2. Regardless, taken together, these in vivo and in vitro findings strongly suggest that the phosphorylation state and activity of Aly2 are directly regulated by Npr1 (see [Figure 9](#F9){ref-type="fig"}).

Aly1 and Aly2 Localize to Endosomes
-----------------------------------

To determine where Aly1 and Aly2 reside within the cell, we examined colocalization of functional Aly1 and Aly2 GFP or RFP fusions with fluorescently tagged trafficking markers. Both Aly1 and Aly2 exhibited diffuse cytoplasmic fluorescence and localized to multiple intracellular foci ([Figure 7](#F7){ref-type="fig"}A), as expected for soluble proteins that associate with membrane compartments. Aly1 and Aly2 colocalized with FM4-64--stained structures at 2 min (marks early endosomes/TGN) and 8 min (marks late endosomes/MVB) after dye internalization ([@B57]; [@B34]; [@B16]; [Figure 7](#F7){ref-type="fig"}A). Thus a significant portion of Aly1 and Aly2 localizes to endosomes. Aly1 and Aly2 also partially colocalized with Tlg1 and Tlg2 ([Figure 7](#F7){ref-type="fig"}B), which are t-SNAREs that mediate fusion of vesicles trafficking between early endosomes and the TGN ([@B34]), indicating that Aly1 and Aly2 traffic between TGN/early endosomes. Finally, Aly1 and Aly2 colocalized partially with RFP-tagged Snf7, a component of the ESCRT III complex, indicating that some portion of Aly1 and Aly2 traffic to the MVB ([Figure 7](#F7){ref-type="fig"}C). Reduced function of this Snf7-RFP has been noted and results in its accumulation in class E compartments ([@B25]). Taken together, these results show that Aly1 and Aly2 partition between early and late endosomes.

![Aly1 and Aly2 localize to endosomes. (A) Colocalization of FM4-64--stained compartments with Aly1-GFP (pUG35-Aly1) or Aly2-GFP (pUG35-Aly2) in BY4742 cells was monitored using fluorescence microscopy at 2 and 8 min after endocytosis. Representative colocalizations at 8 min. are shown (white arrows). Quantification of colocalizing Aly-GFP foci with FM4-64 is shown at right. Scale bar, 5 μm. (B) Colocalization (white arrows) of Aly1-mCherry (p34Aly1-mCh) and Aly2-mCherry (p34Aly2-mCh) with Tlg1-GFP (p416-GFP-Tlg1) or Tlg2-GFP (pRS315-GFP-Tgl2) was assessed using fluorescence microscopy. Scale bar, 5 μm. (C) SNF7-mRFP cells expressing Aly1-GFP (pUG35-Aly1) and Aly2-GFP (pUG35-Aly2) were assessed for colocalization (white arrows) using fluorescence microscopy. Scale bar, 5 μm.](zmk0201096070007){#F7}

Aly1 and Aly2 Colocalize and Interact with Clathrin
---------------------------------------------------

β-Arrestins interact directly with cargo proteins and the trafficking machinery, specifically clathrin and AP-2. MS analysis of Aly1- and Aly2-copurifying proteins identified clathrin heavy chain (Chc1) peptides (data not shown) and a subset of Aly1- and Aly2-foci colocalized with Chc1 ([Figure 8](#F8){ref-type="fig"}A). This indicates that Aly1 and Aly2 associate with CCVs and may regulate clathrin-dependent trafficking.

![Aly1 and Aly2 colocalize with and copurify clathrin and adaptor complex subunits. (A) *CHC1*-mRFP cells expressing Aly1-GFP (pUG35-Aly1) and Aly2-GFP (pUG35-Aly2) were assessed for colocalization (white arrows) using fluorescence microscopy. Scale bar, 5 μm. (B) GST (pKK212), GST-Aly1 (pKK212-Aly1) or GST-Aly2 (pKK212-Aly2) were purified from extracts of BJ5459 cells with grown in SC-0.25% NH~4~. Copurification of clathrin heavy chain (Chc1), the β-subunit of AP-1 (Apl2), and the β-subunit of AP-2 (Apl1) were assessed by WB (pulldown, PD). Samples were run on one gel, but line denotes lane removal. (C) Growth of WT (BY4741), *apl1*Δ (6802), or *apl2*Δ (4985) cells with pRS425, -Aly1, or -Aly2 on MIN-0.5% NH~4~ ± AzC. (D) A schematic of illustrating the regions of the AP-1 complex and Aly1/Aly2 arrestins used in these in vitro binding studies is presented. GST, GST-Apl4 E/H (aa 609-832) and GST-Apl2 E/H (aa 471-726) were purified and binding of pET-Aly1-NArr (aa 1-328), pET-Aly1-Tail (aa 521-915), pET-Aly2-NArr (aa 1-341), or pET-Aly2-Tail (aa 530-1046) was assessed by WB (PD, pulldown).](zmk0201096070008){#F8}

Clathrin is recruited to nascent vesicles by AP complexes; AP-1 mediates TGN-endosome trafficking ([@B56]; [@B60]), whereas AP-2 associates with endocytic CCVs ([@B7]; [@B9]). MS analysis identified peptides from AP-1 subunits copurifying with Aly1 (data not shown), and a yeast proteomics study identified copurification of Aly2 with AP-2 subunits ([@B30]). We confirmed and extended these results; Chc1 and an AP-1 subunit (Apl2) were enriched significantly in purifications of both Aly1 and Aly2 compared with the GST control ([Figure 8](#F8){ref-type="fig"}B) and an AP-2 subunit (Apl1) copurified with GST-Aly2 but not with GST or GST-Aly1 ([Figure 8](#F8){ref-type="fig"}B). Aly1 and Aly2 association with AP-1 is consistent with Aly1 and Aly2 localization to endosomes and further supports an endosome-TGN trafficking function for these α-arrestins.

To determine if AP-1 or AP-2 are required for Aly1- or Aly2-dependent nutrient permease trafficking, *ALY1* or *ALY2* was overexpressed in cells lacking the β-subunit of AP-1 or AP-2 (Apl2 and Apl1, respectively; referred to here as *AP-1*Δ or *AP-2*Δ), and AzC sensitivity was monitored. Wild-type and *AP-2*Δ cells containing a vector grew similarly on AzC-medium ([Figure 8](#F8){ref-type="fig"}C). However, *AP-1*Δ vector control cells were slightly resistant to AzC ([Figure 8](#F8){ref-type="fig"}C), suggesting that AP-1 influences nutrient permease trafficking to the PM. *ALY1* overexpression increased the AzC sensitivity of wild-type, *AP-1*Δ, and *AP-2*Δ cells; thus Aly1 acts independently of AP-1 and AP-2 to increase amino acid uptake at the cell surface. In contrast, overexpression of *ALY2* fails to increase AzC sensitivity in *AP-1*Δ cells ([Figure 8](#F8){ref-type="fig"}C). These findings demonstrate a function for AP-1 in nutrient permease trafficking and establish that Aly2, but not Aly1, requires AP-1 to facilitate permease recycling from endosomes to the TGN and/or PM. In yeast AP-1 regulates endosome-TGN trafficking of Chs3 (chitin synthase III) ([@B56]). Neither deletion nor overexpression of *ALY1* or *ALY2* altered Chs3 localization (Figure S3, A and B), indicating that Aly1 and Aly2 selectively modify the trafficking of AP-1-dependent cargo proteins.

We next examined direct interactions of Aly1 and Aly2 with the β- and γ-subunits of AP-1 (Apl2 and Apl4, respectively). We focused on Apl2 and Apl4 because they are structurally similar to the β-subunit of AP-2, which is the binding partner for mammalian β-arrestins ([@B32]). Apl2 and Apl4 are comprised of a ear/hinge domain (E/H), which interacts with clathrin and other trafficking factors ([@B61]; [@B12]; [@B13]), and a core domain, which interacts with other AP-1 proteins ([@B7]). GST-fusions of the Apl2-Core, Apl2-E/H and Apl4-E/H were purified from *E. coli* and their binding to recombinant, S-tagged Aly1 and Aly2 domains assessed. Aly1 and Aly2 were divided into three regions: 1) the N-terminal arrestin-fold (NArr), 2) the C-terminal arrestin-fold (CArr), and 3) a C-terminal tail (Tail; [Figure 8](#F8){ref-type="fig"}D; arrestin-domains based on Phyre structure predictions; [@B5]; [@B28]). None of the arrestin constructs copurified with Apl2-Core (data not shown) or Apl2-E/H ([Figure 8](#F8){ref-type="fig"}D). Importantly, both Aly1- and Aly2-NArr interacted strongly and specifically with Apl4-E/H ([Figure 8](#F8){ref-type="fig"}D). A weaker interaction between the Aly1-Tail and Apl4-E/H was also observed ([Figure 8](#F8){ref-type="fig"}D). Because the Aly2-Tail was expressed at extremely low levels in *E. coli*, its interaction with Apl4 E/H could not be determined ([Figure 8](#F8){ref-type="fig"}D). Interactions of the Aly1- and Aly2-CArr could not be assessed as they copurified with GST-alone (data not shown). From these in vitro studies, we conclude that the NArr domains of Aly1 and Aly2 bind directly and specifically to the ear/hinge domain of Apl4, the γ-subunit of AP-1. Together our results provide evidence that the Aly2--AP-1 interaction is functionally important for Gap1 trafficking, and establish that, like β-arrestins, α-arrestins associate directly with clathrin-adaptor complexes.

DISCUSSION
==========

In many cells, delivery of permeases to the PM is regulated by nutrients. For example, the Glut4 glucose transporter is sequestered in intracellular compartments and rapidly translocates to the PM to clear bloodstream glucose when muscle or adipose cells are exposed to insulin ([@B24]). This clinically important response is compromised in type II diabetic patients. Similarly, in yeast grown on a preferred nitrogen source, Gap1 never reaches the PM, yet cells maintain ∼3500 Gap1 molecules in intracellular pools ([@B46]; [@B59]) so that Gap1 can be rapidly redistributed to the PM upon nitrogen starvation. The molecular mechanisms by which nutrients regulate such trafficking events are the subject of intense investigation. These studies demonstrate a novel role for arrestins as regulators of protein recycling and expand the repertoire of arrestin trafficking functions beyond their well-documented endocytic role. Furthermore, we provide the first evidence that, like β-arrestins, α-arrestins regulate trafficking by interacting directly with specific vesicle coat and signaling proteins, i.e., the clathrin adaptor AP-1 and Npr1 kinase.

Model of Aly1- and Aly2-mediated Trafficking
--------------------------------------------

We propose that Aly1 and Aly2 promote Gap1 recycling from endosomes to the TGN and/or PM. Under nitrogen-replete conditions, Gap1 PM-activity is low as most of the permease is targeted to the vacuole for degradation. Under these conditions, Aly1 and Aly2 promote Gap1 recycling from endosomes, thereby increasing total Gap1 levels by rescuing some of the permease from vacuolar degradation ([Figure 9](#F9){ref-type="fig"}). When nitrogen is limiting, Gap1 endosomal recycling is activated, causing a rapid increase in Gap1 activity at the PM; Aly1 and Aly2 are required to redistribute Gap1 under these conditions and act through distinct pathways with different proteins ([Figure 9](#F9){ref-type="fig"}). Gap1 vesicles exiting endosomes may transit the TGN, which we favor for Aly2-mediated trafficking given its functional and physical interactions with AP-1, Lst4, and Npr1, or travel directly to the PM ([Figure 9](#F9){ref-type="fig"}). Specific trafficking pathways regulated by Aly1 await identification. Our studies clearly demonstrate that endosomal recycling of Gap1 occurs via multiple routes, and establish Aly1 and Aly2 as tools that can be used to identify mechanisms governing nutrient-regulated Gap1 trafficking.

![Model of Aly1- and Aly2-dependent, nutrient-regulated, Gap1 trafficking. Under nitrogen replete conditions, the majority of Gap1 is trafficked from the TGN to the endosome/vacuole without ever transiting the PM; Aly1/Aly2-dependent endosomal recycling of Gap1 is reduced, but contributes to overall Gap1 levels by diverting a portion of the permease from the endosome/vacuolar pathway. Npr1 is inactive. Under nitrogen starvation conditions, newly synthesized Gap1 transits from the TGN to PM, and Gap1 recycling from endosomal compartments is up-regulated. Npr1 is active. Aly1 and Aly2 mediate trafficking of Gap1 from endosomal compartments back to the TGN and/or the PM through two distinct pathways. Aly2 requires AP-1, Lst4, and Npr1 to mediate Gap1 recycling, and is proposed to operate in endosome-to-TGN trafficking based on the known activities of Lst4 and AP-1 in this interval. Aly1 functions independently of known recycling factors and may regulate Gap1 recycling from endosomes through multiple pathways that either go to the TGN and/or directly back to the PM. Black lines denote Gap1 trafficking paths, with thicker lines indicating the predominant trafficking pathways in that nutrient condition.](zmk0201096070009){#F9}

α-Arrestins Interact with Clathrin and Adaptins to Regulate Trafficking
-----------------------------------------------------------------------

β-Arrestins bind directly to clathrin and the β-subunit of AP-2 to package cargo proteins in endocytic vesicles ([@B18]; [@B32]). Similarly, Aly1 and Aly2 copurify with clathrin and an AP-1 subunit in vivo and interact directly with the γ-subunit of AP-1 in vitro. Aly1 and Aly2 may promote incorporation of Gap1 into clathrin- and AP-1--coated vesicles that transit from endosomes to the TGN, a trafficking interval in which clathrin/AP-1 operate ([@B56]; [@B60]). In vivo, Aly2 requires AP-1 to affect Gap1 trafficking. In contrast, Aly1 altered Gap1 activity in cells lacking AP-1, thus Aly1 may regulate multiple classes of Gap1-containing vesicles. Aly2 (but not Aly1) interacts with the endocytic adaptor, AP-2 ([@B7]; [@B9]). In addition to an endosomal recycling function, Aly2 may regulate endocytosis of other cargos.

We show that Aly1 and Aly2 interact directly with the γ-subunit of AP-1 (Apl4), which has not been previously reported for any arrestin. β-Arrestins bind to AP-2 through a conserved, C-terminal tail motif ([@B14]) that is not conserved in α-arrestins ([@B35]). Although we find that the Aly1 C-terminal tail binds weakly to Apl4, there is a robust interaction between the N-terminal arrestin-domains of both Aly1 and Aly2 and the ear/hinge domain of Apl4. This identifies a novel mode of association with the trafficking machinery that may be conserved in other arrestins; β-arrestins required for vision also lack the conserved C-terminal tail motif responsible for AP-2 binding ([@B29]).

α-Arrestins Associate with Signaling Proteins to Control Trafficking Decisions
------------------------------------------------------------------------------

Endocytosis of the yeast lysine permease, Lyp1, in response to excess ligand is regulated by the α-arrestin, Ldb19, whereas stress-induced endocytosis of Lyp1 is controlled by α-arrestin, Ecm21 ([@B35]). Other α-arrestins also mediate cargo endocytosis selectively in response to specific environmental cues ([@B38]), suggesting that signaling controls α-arrestin function; however, mechanisms underlying this regulation have not been identified.

Extracellular cues induce phosphorylation changes in β-arrestins that alter their trafficking and signaling activities ([@B49]). Similarly, we find that Aly2 interacts with and is directly phosphorylated by the nutrient-regulated kinase, Npr1. Nitrogen starvation activates Npr1 by relieving TORC1-inhibtion, and Npr1 is required for Gap1 translocation to the PM under these conditions ([@B11]). The mechanism by which Npr1 modifies Gap1 trafficking has been elusive; the only Npr1 substrate identified, Rho5, does not function in trafficking ([@B3]). Our work is the first to identify a possible mechanism by which Npr1-dependent nutrient signaling impacts Gap1 distribution. Future studies will test the hypothesis that Npr1 positively regulates the ability of Aly2 to incorporate Gap1, and other Npr1-responsive permeases, into AP-1/clathrin coated vesicles ([@B48]; [@B40]; [@B6]).

Regulation of Arrestins by Ubiquitination
-----------------------------------------

Ubiquitination is a critical sorting determinant in protein trafficking. Nine of the 10 yeast α-arrestins, including Aly1 and Aly2, are ubiquitinated by the Rsp5 ubiquitin ligase ([@B27]; [@B21]; [@B35]). Aly1 and Aly2 mutants lacking Rsp5-binding sites are not ubiquitinated, and though present at increased levels, these mutant proteins fail to increase Gap1 levels at the PM (O\'Donnell and Cyert, unpublished observations). Thus, Aly1 and Aly2 stability is Rsp5-dependent, as is Aly-mediated Gap1 trafficking. Rsp5 regulates key Gap1-trafficking decisions: Gap1 monoubiquitination at the PM stimulates endocytosis, whereas Gap1 polyubiquitination directs trafficking in the MVB ([@B11]; [@B23]; [@B52]; [@B44]). Ubiquitination is a dynamic modification, and ubiquitin chains are remodeled by addition and removal of ubiquitin as proteins transit the trafficking pathway; Rsp5 interacts with a deubiquitinating enzyme, Ubp2, which also influences protein trafficking ([@B27]). Aly1 and Aly2 may serve as Rsp5-adaptors to regulate Gap1 ubiquitination in endosomal compartments and/or Rsp5-mediated ubiquitination of Aly1 and Aly2 may regulate their localization/function.

Expanded Trafficking Roles for Arrestins
----------------------------------------

We propose a new role for two α-arrestins as endocytosis-independent regulators of intracellular protein trafficking. The intracellular sorting we describe and arrestin-mediated endocytosis have functional similarities. We speculate that regulation of intracellular trafficking is a conserved arrestin function. In support of this idea, Vps26, a component of the retromer complex involved in endosome-to-TGN trafficking ([@B42]), is distantly related to α-arrestins and has a strikingly similar crystal structure to β-arrestins ([@B51]). In addition to their endocytic role, β-arrestins regulate postendocytic endosome-to-PM recycling of membrane cargos. Finally, Bul1 and Bul2, Rsp5-adaptors involved in TGN-to-endosome sorting and endocytosis, are structurally related to arrestins ([@B38]). Thus, arrestin-fold domains provide a versatile architecture adaptable to many trafficking functions. As arrestin family members, Aly1 and Aly2 are ideally suited for the nutrient-dependent regulation of intracellular protein stores, which requires the convergence of signaling pathways with the protein trafficking machinery.
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ALY

:   arrestin-like yeast protein

AP-1

:   adaptor protein complex 1

AP-2

:   adaptor protein complex 2

AzC

:   azetidine 2-carboxylic acid

CArr

:   C-terminal arrestin-fold

E/H

:   adaptin ear/hinge domain

MIN

:   minimal medium

MVB

:   multivesicular body

NArr

:   N-terminal arrestin-fold

NH~4~

:   ammonium

PM

:   plasma membrane

SC

:   synthetic complete medium

TGN

:   *trans*-Golgi network

WB

:   Western blot.
